Document is current
Any future updates will be listed below
-
Authors
Kreidieh, Bahij
Keramati, Ali
Kowey, Peter R.
- License Information
-
More Information
Chapter History
First Online: 24 May 2024
Funding
: The authors have no funding sources to disclose.
: Dr. Kowey is a consultant for Medtronic, Sanofi, InCarda, Milestone, Novartis, Acesion, Johnson & Johnson, BMS, Boehringer, Anthos, Huya and Pfizer; he chairs the NCDR EP steering committee at the ACC; he has served on the steering committee of the CABANA trial; and he was a sub-investigator for the AFFIRM trial. All other authors have reported that they have no relationships relevant to the contents of this chapter to disclose.
